Part-Time Pediatric Speech-Language Pathologist

Cortica - Neurodevelopmental; Irvine (CA); On-site; USD 76,000 - 90,000; Part time

Benefits offered by this job

Medical insurance

Dental insurance

Vision insurance

401(k) with company matching

Paid holidays and wellness days

Life insurance

Disability insurance options

Tuition reimbursements for PROFESS.DEV

Referral bonuses

Job summary

Cortica is seeking a part-time Pediatric Speech-Language Pathologist in Irvine, CA to join a growing multi-disciplinary team. The role emphasizes evidence-based assessment, collaborative treatment planning, and patient-centered care, with a focus on children with neurodevelopmental differences.

The position offers a supportive culture and opportunities to contribute to program development. Applicants must be licensed in California and are expected to deliver high-quality therapy, maintain

Qualifications

• Licensed Speech-Language Pathologist in California.
• Excellent clinical skills.
• Desire to work in a multi-disciplinary clinical setting.
• Flexible and open to learning.

Responsibilities

• Establish speech and language treatment goals through dynamic and standardized assessment tools.
• Consult with multi-disciplinary team to create collaborative treatment plans and integrative strategies.
• Provide individual therapy sessions as well as group and/or co-treats with other disciplines as appropriate.
• Maintain patient records and documentation in accordance with regulations and company policy.

Skills

CA Licensure (SLP)

Multidisciplinary teamwork

HIPAA knowledge

Child-focused therapy

Job description

Cortica is seeking a part-time Pediatric Speech-Language Pathologist in Irvine, CA to join a growing multi-disciplinary team. The role emphasizes evidence-based assessment, collaborative treatment planning, and patient-centered care, with a focus on children with neurodevelopmental differences.

The position offers a supportive culture and opportunities to contribute to program development. Applicants must be licensed in California and are expected to deliver high-quality therapy, maintain